Alembic Pharmaceuticals' Bioequivalence Facility located at Vadodara was inspected by US Food & Drug Administration (USFDA) between 12 August, 2019 to 16 August, 2019 and between 12 August, 2019 to 20 August, 2019 for a) Bioequivalence Bioanalytical; and b) Bioequivalence Clinical.
There were no 483s issued by USFDA at the end of the inspection.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
